The Analyst Landscape: 13 Takes On Edwards Lifesciences
The Analyst Landscape: 13 Takes On Edwards Lifesciences
分析师视角下的爱德华生命科学：13种看法
13 analysts have expressed a variety of opinions on Edwards Lifesciences (NYSE:EW) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的季度里，有13名分析师对爱德华生命科学(NYSE: EW)发表了各种不同的意见，提供了从看好到看淡的不同意见。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $96.23, a high estimate of $107.00, and a low estimate of $85.00. Surpassing the previous average price target of $90.75, the current average has increased by 6.04%.
分析师12个月的目标价格揭示了平均目标96.23美元，最高预估107.00美元和最低预估85.00美元。目前的平均价格目标高于以前的90.75美元，增长了6.04%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析师评级：全面解析
The perception of Edwards Lifesciences by financial experts...
通过最近的分析师...
登录免费看全文
登录/注册